The Philippines

The Philippines: an attractive Self-Prescription and Pharma market 

The Philippines have a really attractive Self-Prescription and Pharma market that you should consider if you are looking to expand your business internationally. 

The Philip­pines can be included among the top ten most attrac­tive OTC and prescription drug mar­kets in the Asia-Pacific region. Unfortunately, their health­care sys­tem is so obso­lete that the mar­ket is unable to meet the health­care prod­uct quota that a big pop­u­la­tion demands.

The OTC and pharma market is currently valued at USD 2,1 billion. It is a fast-growing market – expanding faster than the country’s national output. The self-medication and Rx market should reach USD 5,18 Billion ex-factory in 2040. 

At present, mar­ket access in the Philip­pines—with the help of a sys­tem­at­i­cally selected local part­ner—is still a rel­a­tively sim­ple and non-cost-intensive option. The OTC and Pharma mar­kets in neigh­bour­ing coun­tries, such as Thai­land and Malaysia, also show some poten­tial, albeit not on the level of the TRIUMPH markets.

If you are planning on entering the Philippines, our expertise and long-standing network can support you. The Chameleon Pharma Consulting Group has extensive OTC and pharma expertise in South East Asian markets, and we would be thrilled to help you to take advantage of the golden opportunities this region has to offer!